Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IgG4 serum levels in Graves' orbitopathy.
Comi S, Lanzolla G, Cosentino G, Maglionico MN, Posarelli C, Menconi F, Santini F, Elisei R, Marinò M. Comi S, et al. Among authors: lanzolla g. J Endocrinol Invest. 2023 Dec 21. doi: 10.1007/s40618-023-02265-3. Online ahead of print. J Endocrinol Invest. 2023. PMID: 38127192
Statins in Graves Orbitopathy: A New Therapeutic Tool.
Lanzolla G, Comi S, Cosentino G, Pakdel F, Marinò M. Lanzolla G, et al. Ophthalmic Plast Reconstr Surg. 2023 Dec 1;39(6S):S29-S39. doi: 10.1097/IOP.0000000000002525. Epub 2023 Dec 4. Ophthalmic Plast Reconstr Surg. 2023. PMID: 38054983 Review.
Oxidative phosphorylation in bone cells.
Sabini E, Arboit L, Khan MP, Lanzolla G, Schipani E. Sabini E, et al. Among authors: lanzolla g. Bone Rep. 2023 May 23;18:101688. doi: 10.1016/j.bonr.2023.101688. eCollection 2023 Jun. Bone Rep. 2023. PMID: 37275785 Free PMC article.
Absence of a relationship between vitamin D and Graves' orbitopathy.
Lanzolla G, Di Matteo L, Comi S, Cosentino G, Menconi F, Maglionico MN, Posarelli C, Figus M, Marinò M. Lanzolla G, et al. J Endocrinol Invest. 2023 Aug;46(8):1717-1721. doi: 10.1007/s40618-023-02017-3. Epub 2023 Jan 25. J Endocrinol Invest. 2023. PMID: 36696067 No abstract available.
Presentation of Graves' orbitopathy within European Group On Graves' Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III).
Schuh A, Ayvaz G, Baldeschi L, Baretić M, Bechtold D, Boschi A, Brix TH, Burlacu MC, Ciric J, Covelli D, Currò N, Donati S, Eckstein AK, Fichter N, Führer D, Horn M, Jabłońska-Pawlak A, Juri Mandić J, Kahaly GJ, Konuk O, Langbein A, Lanzolla G, Marcocci C, Marinò M, Miśkiewicz P, Beleslin BN, Pérez-Lázaro A, Pérez-López M, Ponto KA, Quinn A, Rudofsky G, Salvi M, Schittkowski MP, Tanda ML, Toruner F, Vaidya B, Hintschich CR. Schuh A, et al. Among authors: lanzolla g. Br J Ophthalmol. 2024 Jan 29;108(2):294-300. doi: 10.1136/bjo-2022-322442. Br J Ophthalmol. 2024. PMID: 36627174 Free PMC article.
Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy.
Lanzolla G, Puccinelli L, Giudetti M, Comi S, Menconi F, Maglionico MN, Posarelli C, Figus M, Marcocci C, Marinò M. Lanzolla G, et al. J Endocrinol Invest. 2023 Feb;46(2):337-344. doi: 10.1007/s40618-022-01906-3. Epub 2022 Aug 27. J Endocrinol Invest. 2023. PMID: 36030301 Free PMC article.
Sirolimus as a second-line treatment for Graves' orbitopathy.
Lanzolla G, Maglionico MN, Comi S, Menconi F, Piaggi P, Posarelli C, Figus M, Marcocci C, Marinò M. Lanzolla G, et al. J Endocrinol Invest. 2022 Nov;45(11):2171-2180. doi: 10.1007/s40618-022-01862-y. Epub 2022 Jul 13. J Endocrinol Invest. 2022. PMID: 35831587 Free PMC article.
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves' Disease Hyperthyroidism During Methimazole Treatment.
Gallo D, Mortara L, Veronesi G, Cattaneo SA, Genoni A, Gallazzi M, Peruzzo C, Lasalvia P, Moretto P, Bruno A, Passi A, Pini A, Nauti A, Lavizzari MA, Marinò M, Lanzolla G, Tanda ML, Bartalena L, Piantanida E. Gallo D, et al. Among authors: lanzolla g. Front Endocrinol (Lausanne). 2022 Jun 15;13:886451. doi: 10.3389/fendo.2022.886451. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35784564 Free PMC article. Clinical Trial.
35 results